BS is a clinically less common but rather severe form of hepatic venous outflow disorder that leads to a vicious cycle which deeply impairs the liver function. The above condition got named after two professionals who first described this syndrome in 1845 and the other one in 1899. However, its aetiolo- gy is multiple, although thrombotic or occlusive disease of the hepatic veins is the most frequent cause of Budd Chiari Syndrome, it may also result from a tumour or membrane compressing the hepatic veins. In this pathological condition, there is little doubt that the role of early diagnosis and treatment cannot be overemphasised because it improves the result of any treatment plan; ultrasound is useful in the initial assessment and follow up of this pathologic condition, specifically the doppler ultrasound.

Nevertheless, for exceptional details of the use of ultrasound, it is germane to mention about the Budd Chiari Syndrome pathophysiology. Regarding the vessels that carry deoxygenated blood from the liver to the inferior vena cava these are referred to as the hepatic veins. When this outflow is blocked, there is accumulation of blood in the liver and this leads to raised pressure in the portal venous system and it leads to liver congestion. In many years, this results to hepatomegaly, and the ita dilation, while in case formation of ascites, hepatic fibrosis and cirrhosis it, if these are left uncared for.

Budd-Chiari Syndrome can be classified into three types based on the location of the obstruction: Type I is defined as the exclusion of the IVC; type II as the exclusion of the major hepatic veins and type III is the exclusion of the minor intrahepatic venues. In any case, the clinical expression of BCS can be polymorphic, spread from asymptomatic forms detected during screening examination to develop fatal acute liver failure with rapid progression of jaundice, encephalopathy and coagulopathy.

The Role of Ultrasound in Diagnosis

Budd Chiari Syndrome or BCS is a rare and sinister hepatic venous outflow tract disease, where hepatic venous outflow is obstructed thus causing a cascade of events that compromises liver function significantly. The name of this condition stems from George Budd who described the syndrome in 1845 and Hans Chiari, who contributed to detailed study of the same in 1899. In any case, the cause of Budd Chiari Syndrome is still not well understood, but it is mainly related to thrombosis or occlusion of hepatic veins and, more rarely, compression by a tumour or membrane. Timely detection and aggressive management are critical to enhancing the patients’ prognosis, and ultrasound proves to have an important part in both the initial diagnosis and monitoring of this challenging disorder with Doppler ultrasound being particularly useful.

First of all, BCS and the suitability of the role of ultrasound in diagnosis and management will be described in brief before going into the details. The hepatic veins are supposed to empty deoxygenated blood from the liver into the inferior vena cava, or the IVC. Cirrhosis may thus be defined as a condition in which outflow is blocked, and blood accumulates in the liver raising pressure in the portal venous system and causing congestion in the liver. It may over time cause hepatomegaly, ascites and if left for long end up with hepatic fibrosis and cirrhosis.

Depending on the type, the clinical presentations may range from the occult form in which the BCS is diagnosed incidentally from the more severe where the patients present with jaundice, encephalopathy and coagulopathy due to fulminant liver failure.

Advanced Ultrasound Techniques

A simple Doppler ultrasound is a highly useful tool in the diagnosis of Budd-Chiari Syndrome; on the other hand, newer techniques including CEUS as well as elastography can be highly valuable in enhancing the capability and information content of the diagnostic processes in Bett-Chiari Syndrome.

However, elastography assesses the liver stiffness that is in positive correlation with fibrosis presence and its extent. Chronic dumping of this pressure and congestion that is seen in Budd Chiari Syndrome also has the potential of causing fibrosis and cirrhosis of the liver. Documentation of fibrosis via elastography facilitates in obtaining prognostic data as well as direct contribution in the treatment plans. This Doppler ultrasound with CEUS along with elastography enables the Clinician to have a realistic view of the hepatic vasculature and the live parenchyma for diagnosis, a stage that usually is very critical for treatment management.

The Management and Follow-Up of Obstetric Pregnancies in Maternal-Foetal Medicine

Apart from the diagnostic functions, ultrasound is further useful for monitoring and managing Budd Chiari Syndrome further. Patients receiving anticoagulation or thrombolysis for medical treatment should have a regular follow-up with ultrasound examination to check the response of therapy and potential complications including new thrombus formation or worsening of hepatic fibrosis.

Also, in the management of PTS, ultrasound is indispensable during follow-up of the patient who may require liver transplantation that is occasionally mandatory in patients with advanced Budd-Chiari Syndrome. After the liver transplant, hepatic artery, portal vein, and hepatic veins are evaluated with Doppler ultrasound for signs of thrombosis, stenosis and other factors which might result in graft dysfunction.

Though the study has shown positive outcome in patients managed with CVC alone, the future of ultrasound in Budd Chiari Syndrome is bright due to following reasons.

New techniques and improvements in the technology of ultrasonography should improve upon the diagnostic capabilities of this disease in the future. Techniques such as three dimensional or 3D ultrasound, for instance, may present possibilities for even better visualization of the hepatic vasculature and thus, permit a more accurate evaluation of anatomic variants and diseases of the network.